Jump to content
Powered by

Tetec AG opens new production facility

On 20th November 2008, Tetec AG opened a new facility for the production of cartilage transplants. The company, a subsidiary of B. Braun Melsungen AG based in Reutlingen, is expanding its production capacities to cater for the growing demand for implants.

The opening of an own production facility is a milestone in Tetec AG’s successful development. The new building will house cleanrooms for the production of joint cartilage implants. The procedure involves removing a patient’s own cartilage cells, for example from a knee joint, and then expanding the cells in the laboratory and implanting them into the damaged joint cartilage area.

Growing market for cartilage transplants

The number of implants produced by Tetec has grown to almost 1,000 per year and the old production facilities at Tetec are no longer able to cater for constantly growing demand. Since its foundation in 2000, Tetec AG has become the market leader for autologous cartilage cell transplantation (ACT) in Europe and is continuing its research into further innovative methods. Some products are close to clinical application and the company also hopes to conquer additional international markets.

Commitment to biotechnology

B. Braun Aesculap has invested around 6.2 million euros into its subsidiary’s new building. Speaking at the opening ceremony, Prof. h.c. Ludwig-Georg Braun, head of B. Braun Melsungen AG, talked of investment in the future and the company’s belief in the huge potential of such innovative technologies despite the long development times necessary to bring such products to market. Increasingly stricter regulations and laws make access to market difficult and risky. Many emerging biotechnology companies have ceased to exist because they lacked a reliable and solid partner like B. Braun, a company which places huge importance on sustainability.

The Lord Mayor of Reutlingen, Barbara Bosch, referred to the positive development of the city’s ‘West’ industrial area adjoining Tübingen, now the city’s new industrial centre. Bosch underlined the city’s intention to do everything it could to provide the conditions for the area’s further positive development.
The chairmen and founders of the young company, Dr. Jürgen Fritz and Dr. Christoph Gaissmaier, were pleased to receive the keys to the new building after weeks of hard work. Dr. Fritz thanked B. Braun Aesculap for financial and other valuable support. He also thanked the Tetec staff for their commitment and enthusiasm that has made successful development of the company possible.

Source: TETEC AG press release, 24 November 2008
Website address: https://www.gesundheitsindustrie-bw.de/en/article/news/tetec-ag-opens-new-production-facility